Jay Shetty PodcastWORLDS TOP OBGYN: #1 Hormone Problem Impacting MILLIONS of Women (This is How You REVERSE it!)
CHAPTERS
- 0:00 – 3:25
The hidden epidemic: massive underdiagnosis of PCOS and endometriosis
Dr. Thaïs Aliabadi opens with a forceful message: most PCOS and endometriosis cases are missed, leaving millions dismissed, untreated, and struggling with pain, mental health symptoms, and infertility. She frames these conditions as whole-body disorders that affect hormones, inflammation, and the nervous system—not just periods or fertility.
- •PCOS: ~75% undiagnosed; endometriosis: >90% undiagnosed (per her clinical view)
- •Both are leading global causes of infertility
- •Symptoms are frequently minimized as “normal,” “in your head,” or “just stress”
- •Hormonal/inflammatory drivers can make calmness and emotional regulation harder
- •Teen girls can be affected early, with pain and symptoms normalized
- 3:25 – 4:25
Are we in a fertility crisis? The ‘unexplained infertility’ gap
Jay asks what a fertility crisis means, and Dr. Aliabadi explains baseline conception rates and where many couples fall through the cracks. She argues that a large portion of “unexplained infertility” is actually undiagnosed PCOS or endometriosis.
- •Typical conception stats: ~50% by 6 months, ~90% by 1 year, ~10% not pregnant
- •After male-factor causes, many remaining cases link to PCOS/endometriosis
- •Underdiagnosis drives the “unexplained” category
- •Earlier identification could prevent years of delays and unnecessary escalation
- 4:25 – 7:52
What PCOS is—and the simple 2-of-3 diagnostic criteria most people miss
Dr. Aliabadi defines PCOS as a chronic hormonal, metabolic, inflammatory, and neurological condition and details the diagnostic framework. She clarifies that PCOS is often misunderstood as “ovarian cysts,” leading to missed diagnoses.
- •PCOS affects ~15% (higher in some regions)
- •Diagnosis requires 2 of 3: ovulation dysfunction, PCOS ovarian morphology/high AMH, and/or androgen excess signs
- •‘Polycystic’ refers to follicles on ultrasound, not cysts
- •Androgen symptoms can include acne, hirsutism, oily skin, and scalp hair thinning
- •PCOS often associates with mood symptoms, PMS, and disordered eating
- 7:52 – 9:49
Why PCOS goes undiagnosed: varied presentations, lean PCOS, and clinician confusion
They explore why PCOS is overlooked despite clear criteria. Dr. Aliabadi emphasizes that symptoms vary widely, and some patients are lean or lack classic testosterone symptoms—so clinicians may dismiss PCOS prematurely.
- •Different PCOS ‘morphologies’ create inconsistent symptom patterns
- •Some patients have regular-ish periods but still have PCOS physiology
- •Lean PCOS exists and can still involve insulin resistance and disordered eating
- •Misbeliefs: “no cysts,” “no high testosterone,” or “no irregular periods” means “no PCOS”
- •Self-education helps patients advocate effectively
- 9:49 – 15:32
PCOS core driver #1: insulin resistance and how it cascades into weight gain and hormone disruption
Dr. Aliabadi lays out insulin resistance as the first domino in PCOS, explaining glucose/insulin physiology and why PCOS patients store more inflammatory visceral fat. She connects elevated insulin to ovarian androgen production and disrupted ovulation.
- •Carbs → glucose → insulin; insulin resistance blocks glucose uptake into cells
- •High insulin promotes visceral fat storage and inflammation
- •Insulin stimulates ovarian theca cells → increased androgens
- •Androgens disrupt follicle development and ovulation, causing irregular cycles
- •Creates a reinforcing loop: insulin → androgens → brain signaling → more androgens
- 15:32 – 20:04
Making PCOS patients insulin-sensitive: diet, walking after meals, supplements, metformin, and GLP-1s
The conversation turns practical: strategies to reduce insulin and improve insulin sensitivity. Dr. Aliabadi highlights low-carb approaches, post-meal walking, exercise, supplements, metformin dosing, and GLP-1 medications for appropriate candidates.
- •Low-carb diet plus 10–20 min walk after meals to lower glucose
- •Regular exercise (cardio multiple times/week) improves insulin sensitivity
- •Supplements may support cellular glucose uptake and reduce inflammation (her product mentioned)
- •Metformin: GI side effects possible; minimum effective dose cited as ~1500 mg/day
- •GLP-1s (e.g., Ozempic/Wegovy class) can improve insulin sensitivity and cycle regularity in PCOS
- 20:04 – 22:40
GLP-1 medications: nutrient concerns, duration, and preventing rebound weight gain
Jay raises concerns about inadequate nutrition on GLP-1s. Dr. Aliabadi distinguishes PCOS treatment from cosmetic use and explains how she sequences GLP-1s with ongoing insulin-resistance therapies to reduce rebound.
- •Nutritional risk is context-dependent; she emphasizes PCOS/medical use vs. vanity use
- •Some patients may require long-term therapy depending on metabolic severity
- •Stopping GLP-1 without addressing insulin resistance can lead to rapid regain
- •Her approach: layer metformin and other supports before tapering GLP-1
- •Goal is sustained insulin sensitivity, not only short-term weight loss
- 22:40 – 31:50
PCOS pillars #2–#4: high androgens, chronic inflammation, and the brain/nervous system
Dr. Aliabadi explains how altered GnRH/LH/FSH signaling maintains high androgens, then connects PCOS to chronic inflammation and neurological effects. She details how unstable estrogen/progesterone plus inflammation can drive anxiety, depression, brain fog, and cravings.
- •High LH becomes chronic (not just mid-cycle), driving persistent androgen production
- •Chronic inflammation sources: visceral fat, stress/cortisol, sleep disruption, frozen follicles, gut issues
- •Inflammation worsens insulin resistance and androgen production (vicious cycle)
- •Hormone instability reduces serotonin balance and disrupts dopamine/motivation
- •Birth control may improve surface symptoms but doesn’t address insulin resistance/inflammation/brain effects alone
- 31:50 – 35:28
How to know if you have PCOS: self-advocacy tools and getting taken seriously
Jay asks about diagnosis and confirmation. Dr. Aliabadi describes symptom-based identification, her online risk calculator, and the need for patients to arrive informed to appointments to counter common dismissal.
- •PCOS can often be suspected from criteria + associated symptoms
- •She references an online questionnaire-based risk tool (not a formal diagnosis)
- •Patients frequently face misconceptions about labs and eligibility for treatments
- •Empowerment strategy: learn the criteria, document symptoms, bring a plan to the visit
- •Goal: move beyond “just birth control” and address all pillars
- 35:28 – 37:14
Painful periods are not normal: recognizing endometriosis symptoms early
They transition to endometriosis, starting with a clear boundary between typical cramps and debilitating pain. Dr. Aliabadi lists hallmark symptoms that should trigger evaluation rather than normalization.
- •Severe pain that disrupts school/work/life is not normal menstruation
- •Red flags: vomiting from pain, ER/urgent care visits, or being unable to function
- •Pain with deep penetrative sex is a key symptom
- •Bladder symptoms with negative cultures and painful bowel movements are warning signs
- •Chronic pelvic pain and bloating often accompany endometriosis
- 37:14 – 42:20
What endometriosis is: inflammatory implants, immune dysfunction, and central sensitization
Dr. Aliabadi defines endometriosis and explains how ectopic tissue responds to monthly estrogen, bleeds, and drives inflammation and scarring. She emphasizes neuroimmune features, nerve-fiber growth, and how years of pain can sensitize the central nervous system.
- •Tissue similar to uterine lining grows outside the uterus (ovaries, tubes, bladder, bowel, etc.)
- •Monthly estrogen stimulates implants → bleeding outside uterus → inflammation/adhesions
- •Immune dysfunction may fail to clear refluxed endometrial cells and can promote implantation
- •Implants can develop blood supply and nerve fibers, producing diverse pain patterns
- •Chronic pain can lead to central nervous system sensitization, anxiety, depression, and PTSD-like symptoms
- 42:20 – 49:47
Most effective endometriosis treatment: hormonal suppression first, surgery when needed—and why surgeries miss it
Dr. Aliabadi argues endometriosis can be clinically diagnosed and that surgery is for treatment when suppression fails or fertility requires it. She explains treatment options, then describes why many laparoscopies miss lesions due to variability in appearance and insufficient surgical expertise.
- •Endometriosis should often be diagnosed clinically from history (not only by surgery)
- •First-line: progesterone-based suppression (pills or IUDs) and/or estrogen-lowering meds (GnRH agents)
- •GnRH therapies can have side effects (hot flashes, mood changes)
- •Advanced disease may require excision by a highly skilled surgeon; she claims very few are trained for complex cases
- •Lesions vary: classic purple glandular spots vs. subtle white-line stromal disease that is often missed
- 49:47 – 58:19
The cost of ignoring endometriosis: egg reserve loss, infertility, pain, mental health, and repeated procedures
Jay asks what happens if endometriosis is left unaddressed. Dr. Aliabadi stresses fertility damage through inflammatory harm to egg quantity/quality and urges early ovarian reserve assessment and strategic suppression, especially when egg freezing isn’t feasible.
- •Inflammation can reduce egg count/quality; ovarian endometriomas carry high risk
- •AMH testing as a simple ovarian reserve screen; consider earlier baselines for high-symptom patients
- •If egg freezing isn’t possible: prioritize suppression and inflammation control
- •Repeated surgeries without ongoing suppression can lead to recurrence and harm
- •Long-term impacts include painful sex/relationship strain, narcotic reliance risk, anxiety/depression, and life disruption
- 58:19 – 1:04:56
Endometriosis and the gut/immune system: leaky gut, SIBO, autoimmune overlap, and IVF complications
They discuss systemic ripple effects, including high rates of GI issues and immune comorbidities. Dr. Aliabadi links endometriosis to leaky gut/SIBO cycles and explains why IVF’s high estrogen can unmask symptoms and associated autoimmune conditions if endo is unrecognized.
- •She cites very high prevalence of leaky gut/SIBO symptoms in endometriosis patients
- •Treating GI symptoms often requires treating endometriosis first, then addressing SIBO
- •Endometriosis may correlate with other autoimmune diseases; one autoimmune increases risk of another
- •IVF doesn’t ‘cause’ autoimmunity but can reveal it (and may flare endometriosis via estrogen)
- •Persistent pain after treatment may require neuromodulators to help desensitize the nervous system
- 1:04:56 – 1:23:31
A scientific, bucket-based infertility workup—and what to do if you’re not getting pregnant
Dr. Aliabadi outlines a structured infertility evaluation: female hormones/egg reserve, male factor, anatomy/tubal testing, endometriosis, PCOS, and autoimmune causes. She emphasizes proactive screening (including pelvic ultrasound) and early intervention—especially after age 35.
- •Key buckets: female labs (thyroid, prolactin, androgens, AMH), male semen analysis, anatomy imaging (pelvic ultrasound, HSG)
- •Assess endometriosis clinically and advocate for specialist care if dismissed
- •Assess PCOS criteria and treat insulin resistance to improve ovulation
- •Autoimmune evaluation is critical in recurrent miscarriage or suggestive symptoms (e.g., antiphospholipid syndrome)
- •After 35: try ~6 months before escalating; she argues proactive screening prevents “unexplained infertility”
